75
Participants
Start Date
August 31, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Flu Vaccine (Year 1)
Participants will receive Fluzone® Quadrivalent High-Dose in the 2022-2023 flu season.
Flu Vaccine (Year 2)
Participants will receive FLUAD® Quadrivalent in the 2023-2024 flu season.
Flu Vaccine (Year 3)
Participants will receive Flublok Quadrivalent in the 2024-2025 flu season.
RECRUITING
UConn Health, Center On Aging, Farmington
UConn Health
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Weill Medical College of Cornell University
OTHER
University of Chicago
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
The Jackson Laboratory
OTHER